The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Servier, BMS, Gilead, Jansen, MSD, Celltrion, Celgene, Roche
Speakers' Bureau - Verastem, Servier, BMS, Gilead, Jansen, MSD, Celltrion, Celgene, Roche
Update of the single-arm phase II L-MIND study of MOR208 + lenalidomide (LEN) in relapsed/refractory diffuse large B-cell lymphoma (R-R DLBCL): Response rates in patient subgroups with poor prognosis.
 
Kami J. Maddocks
Honoraria - Bayer; Novartis; Pharmacyclics; Teva
Research Funding - Bristol-Myers Squibb; Merck; Pharmacyclics
 
Johannes Duell
No Relationships to Disclose
 
Eva González Barca
Consulting or Advisory Role - Celltrion; Gilead Sciences; Janssen; Kowa; Sandoz
Speakers' Bureau - Abbvie; Janssen; Roche; Takeda
Travel, Accommodations, Expenses - Abbvie; Janssen; Roche
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; MorphoSys; Roche; Sandoz-Novartis
Research Funding - Celgene; Celltrion; Janssen; MorphoSys; Roche; Sandoz-Novartis
 
Anna Marina Liberati
No Relationships to Disclose
 
Zsolt Nagy
No Relationships to Disclose
 
Aleš Obr
No Relationships to Disclose
 
Gianluca Gaidano
Honoraria - Abbvie; Janssen; MorphoSys; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie; Janssen; MorphoSys; Sunesis Pharmaceuticals
Speakers' Bureau - Janssen
 
Marc André
No Relationships to Disclose
 
Nagesh Kalakonda
Research Funding - Celgene
 
Martin H. Dreyling
Honoraria - Bayer; Celgene; Gilead Sciences; Janssen; Roche
Consulting or Advisory Role - Acerta Pharma; Bayer; Celgene; Gilead Sciences; Janssen; Novartis; Roche; Sandoz
Research Funding - Celgene (Inst); Janssen (Inst); Mundipharma (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Celgene; Janssen; Roche; Takeda
 
Pier Luigi Zinzani
No Relationships to Disclose
 
Maren Dirnberger-Hertweck
Employment - MorphoSys
 
Johannes Weirather
Employment - MorphoSys
 
Sumeet Vijay Ambarkhane
Employment - MorphoSys
 
Gilles A. Salles
Honoraria - Abbvie; Amgen; Celgene; Gilead Sciences; Janssen; Merck; MorphoSys; Novartis; Roche/Genentech; SERVIER; Takeda
Consulting or Advisory Role - Acerta Pharma; Celgene; Epizyme; Gilead Sciences; Janssen; Kite, a Gilead company; Merck; morphosys; Novartis; Pfizer; Roche/Genentech; SERVIER